Skip to main content
Sign In
 

Kidney Disease Pharmacology: Drugs, Biologics, Delivery & Devices

Lab Members


Uma Fogueri, BS, MS: PhD candidate in Pharmaceutical Sciences

Email: Uma.Fogueri@CUAnschutz.edu

Uma completed her BS degree in Pharmaceutical Sciences from Goa University (India). She completed her MS degree in Physical Computational Chemistry from the University of North Texas in Denton TX. Uma’s research is in drug delivery of a small molecule drug, pharmacokinetics and physiologically based pharmacokinetics (PBPK) of a monoclonal antibody. Uma is also trying to evaluate​ the role of vitamin D in kidney diseases by focusing on drug metabolizing enzymes and transporter expression.

Amandla Atilano-Roque, BS: PhD candidate in Toxicology

Email: Amandla.Atilano-Roque@ucdenver.edu

Amandla completed her BS degree from Mills College in California. Her research focuses on characterizing xenobiotic transporters as mediators of HMG-CoA reductase inhibitor uptake and efflux and exposure in the CKD population. In addition, Amandla is involved in patient recruitment and clinical coordination of the drug metabolizing enzyme and transporter function in chronic kidney disease study.

Stacey Tuey, BS: PhD student in Pharmaceutical Sciences

Email: Stacey.Tuey@CUAnschutz.edu

Stacey completed her BS degree in Chemistry from California State Polytechnic University of Pomona. She then went on to work as a research assistant in the microbiology R&D department at Johnson & Johnson’s medical device company, Advanced Sterilization Products for 3 years. Stacey’s research is in drug delivery and cisplatin nephrotoxicity in kidney diseases.

Cara Chang, BS, MS: Doctor of Pharmacy Honors student

Email: Cara.Chang@ucdenver.edu

Cara completed her BA degree in Biological Sciences from the University of Southern California and her MS degree in Cell and Molecular Biology from the John A. Burns School of Medicine, University of Hawaii. Cara’s research is in evaluating the role of pharmacogenomics and novel urinary biomarkers in the early detection of cisplatin induced acute kidney injury.

Madeleine Gomez

​​​​​​​